Bladder cancer: Allelic deletions at and around the retinoblastoma tumor suppressor gene in relation to stage and grade

Clinical Cancer Research

Volumn 6, Issue 2, 2000, Pages 610-615

  Wada, Takashi ^a,b   Louhelainen, Jari ^a   Hemminki, Kari ^a   Adolfsson, Jan ^b   Wijkström, Hans ^b   Norming, Ulf ^b   Borgström, Erik ^b   Hansson, Johan ^b   Sandstedt, Bengt ^c   Steineck, Gunnar ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Karolinska Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER STAGING; CHROMOSOME 13; DNA DETERMINATION; FLUORESCENCE; GENE DELETION; GENE LOSS; HETEROZYGOSITY LOSS; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ALLELES; BIOPSY; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 13; DNA; GENES, RETINOBLASTOMA; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; URINARY BLADDER NEOPLASMS;

EID: 0033965916     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Orlow, I., Lacombe, L., Hannon, G. J., Serrano, M., Pellicer, I., Dahlbagni, G., Reuter, V. E., Zhang, Z. F., Beach, D., and Cordon-Cardo, C. Deletion of the p16 and p15 genes in human bladder tumors. J. Natl. Cancer Inst., 87: 1524-1529, 1995.
2. Tsai, Y. C., Nichols, P. W., Hiti, A. L., Williams, Z., Skinner, D. G., and Jones, P. A. Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer. Cancer Res., 50: 44-47, 1990.
3. Olumi, A. F., Tsai, Y. C., Nichols, P. W., Skinner, D. G., Cain, D. R., Bender, L. L., and Jones, P. A. Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder. Cancer Res., 50: 7081-7083, 1990.
4. Cairns, P., Proctor, A. J., and Knowles, M. A. Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma. Oncogene, 6: 2305-2309, 1991.
5. Knowles, M. A., Elder, P. A., Williamson, M., Cairns, J. P., Shaw, M. E., and Law, M. G. Allelotype of human bladder cancer. Cancer Res., 54: 531-538, 1994.
6. Li, M., Zhang, Z. F., Reuter, V. E., and Cordon-Cardo, C. Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder. Am. J. Pathol., 149: 229-235, 1996.
7. Polascik, T. J., Cairns, P., Chang, W. Y., Schoenberg, M. P., and Sidransky, D. Distinct regions of allelic loss on chromosome 4 in human primary bladder carcinoma. Cancer Res., 55: 5396-5399, 1995.
8. Takle, L. A., and Knowles, M. A. Deletion mapping implicates two tumor suppressor genes on chromosome 8p in the development of bladder cancer. Oncogene, 12: 1083-1087, 1996.
9. Habuchi, T., Luscombe, M., Elder, P. A., and Knowles, M. A. Structure and methylation-based silencing of a gene (DBCCRI) within a candidate bladder cancer tumor suppressor region at 9q32-133. Genomics, 48: 277-288, 1998.
10. Shaw, M. E., and Knowles, M. A. Deletion mapping of chromosome 11 in carcinoma of the bladder. Genes Chromosomes Cancer (Philadelphia), 13: 1-8, 1995.
11. Sellers, W. R., and Kaelin, W. G., Jr. Role of the retinoblastoma protein in the pathogenesis of human cancer. J. Clin. Oncol., 15: 3301-3312, 1997.
12. Dalbagni, G., Presti, J., Reuter, V., Fair, W. R., and Cordon-Cardo, C. Genetic alterations in bladder cancer. Lancet, 342: 469-479, 1993.
13. Miyamoto, H., Shuin, T., Ikeda, I., Hosaka, M., and Kubota, Y. Loss of heterozygosity at the p53. RB, DCC and APC tumor suppressor gene loci in human bladder cancer. J. Urol., 155: 1444-1447, 1996.
14. Habuchi, T., Ogawa, O., Kakehi, Y., Ogura, K., Koshiba, M., Hamazaki, S., Takahashi, R., Sugiyama, T., and Yoshida, O. Accumulated allelic losses in the development of invasive urothelial cancer. Int. J. Cancer, 53: 579-584, 1993.
15. Ishikawa, J., Xu, H. J., S. X., Yandell, D. W., Maeda, S., Kamidono, S., Benedict, W. F., and Takahashi, R. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas. Cancer Res., 51: 5736-5743, 1991.
16. Bartek, J., Bartkova, J., and Lukas, J. The retinoblastoma protein pathway in cell cycle control and cancer. Exp. Cell Res., 237: 1-6, 1997.
17. Toguchida, J., McGee, T. L., Paterson, J. C., Eagle, J. R., Tucker, S., Yandell, D. W., and Dryja, T. P. Complete genomic sequence of the human retinoblastoma susceptibility gene. Genomics, 17: 535-543, 1993.
18. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 81: 323-330, 1995.
19. Mulligan, G. And Jacks, T. The retinoblastoma gene family: cousins with overlapping interests. Trends Genet., 14: 223-229, 1998.
20. Varley, J. M., Armour, J., Swallow, J. E., Jeffreys, A. J., Ponder, B. A., T'Ang, A., Fung, Y. K., Brammar, W. J., and Walker, R. A. The retinoblasoma gene is frequently altered leading to loss of expression in primary breast tumours (published erratum appears in Oncogene, 5: 245, 1990). Oncogene, 4: 725-729, 1989.
21. Varley, J. M., Armour, J., Swallow, J. E., Jeffreys, A. J., Ponder, B. A., T'Ang, A., Fung, Y. K., Brammar, W. J., and Walker, R. A. The retinoblasoma gene is frequently altered leading to loss of expression in primary breast tumours (published erratum appears in Oncogene, 5: 245, 1990). Oncogene, 4: 725-729, 1989.
22. Cawkwell, L., Lewis, F. A., and Quirke, P. Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by flourescent multiplex polymerase chain reaction. Br. J. Cancer, 70: 813-818, 1994.
23. Bookstein, R., Shew, J. Y., Chen, P. L., Scully, P., and Lee, W. H. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science (Washington DC), 247: 712-715, 1990.
24. Sambrook, J., Fritschookstein, E. F., and Maniatis, T. Molecular Cloning. A Laboratory Manual, Ed. 2. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1989.
25. Onadim, Z., Hungerford, J., and Cowell, J. K. Follow-up of retinoblasoma patients having prenatal and perinatal predicitions for mutant gene carrier status using intragenic polymorphic probes from the RBI gene. Br. J. Cancer, 65: 711-716, 1992.
26. Hall, R. R., and Prout, G. R. Staging of bladder cancer: is the tumor, node, metastasis system adequate? Semin. Oncol., 17: 517-523, 1990.
27. Bergkvist, A., Ljungqvist, A., and Moberger, G. Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir. Scand., 130: 371-378, 1965.